Scarsdale, NY—Prominently featured in The Inner Circle, Owen A. O’Connor, M.D., Ph.D., is acknowledged as a Feature Life Achiever for his contributions to the fields of Oncology and Drug Discovery.
Dr. O’Connor began his pursuit of higher education at Manhattan College in New York where he earned a Bachelor of Science degree in Environmental Science. He completed a Ph.D. in Environmental Medicine at the New York University Medical School, where he studied the mechanisms of chemical carcinogenesis. He completed a Medical Degree from the University of Medicine and Dentistry of New Jersey and finished an internship and residency in Internal Medicine at the New York Hospital – Cornell University Medical Center. He additionally completed two fellowships, one in medical oncology in the Department of Medicine under the Clinical Investigator Program, and in the laboratory of Dr. Joseph R. Bertino, at Memorial Sloan Kettering Cancer Center; and a second in clinical pharmacology in the Division of Pharmacology in the Department of Medicine New York Hospital – Cornell University Medical School. A leader in his field, he was appointed Chief Medical Oncology Fellow in the Department of Medicine at Memorial Sloan Kettering Cancer Center.
Internationally renowned as an oncologist and expert in drug discovery and development, the doctor is a specialist in diagnosing and treating all forms of lymphoma. He has more than 20 years of experience in academic medicine and invented and pioneered the development of several first-in-class drugs to treat blood cancer. Dr. O’Connor also co-invented a drug for T-cell lymphoma, which has now been approved in over 35 countries worldwide. A testament to his acumen and exceptional education, the doctor has held several prestigious leadership positions at major cancer centers in New York City, including Memorial Sloan Kettering Cancer Center; New York University Medical Center; and Columbia University Medical Center.
According to Dr. O’Connor, his scientific interests are focused on developing novel, small molecules for blood cancer treatment. He is focused on chemistry through preclinical modeling and early-phase clinical studies to regulatory Phase 3 studies. Dr. O’Connor has published more than 250 articles in peer-reviewed journals, books, and book chapters, and has completed reviews on managing lymphoma and drug discovery. He is the editor of the first textbook on the Peripheral T-Cell Lymphomas and is now editing a new series of books for Wiley Sciences on Precision Cancer Therapies.
Dedicated to providing the latest innovations in the field and exploring inventive ways to treat cancer, the doctor is affiliated with the Scientific Advisory Board for the Lymphoma Research Foundation; the Leukemia Lymphoma Society; the American Society of Clinical Oncology; the American Association for Cancer Research; the American Society of Hematology; and has received countless awards for his research, including being named to America’s Top Cancer Doctor; cited among the Top 50 Irish-Americans in Science and Medicine by the Irish government; was inducted into the New Jersey Inventors Hall of Fame; and has been a Castle Connolly Top Doctor since 2011. The doctor also received the American Cancer Society Research Professorship, the most prestigious honor bestowed by the Society.
Aside from his professional pursuits, Dr. O’Connor enjoys creative photography, travel, and spending time at his second home on Cape Cod. He actively supports the Association for the Preservation of Cape Cod and the Cape Cod Arts Center.
About Author
